Effectiveness of FDA’s new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage

Abstract

The new warning label mandated by FDA is effective in improving consumer risk perception of potential liver damage and may encourage protective behaviour. However, future studies are essential to assess the impact of the new label on actual changes in consumer behaviour and subsequent reduction in acetaminophen-related morbidity and mortality.